DNA Blood Test Could End Risky Tests For Down's Syndrome

DNA in a pregnant woman's blood can reliably show whether her foetus has Down's syndrome, thus hugely reducing the need for invasive test procedures such as amniocentesis, research

An accurate new DNA blood test could almost eliminate the need for risky invasive tests for Down's syndrome, according to a research published.

Down's syndrome, a major developmental disorder also called trisomy 21, occurs in around one in every 800 live births.

Down Syndrome - Trisomy 21, Causes, Symptoms, Diagnosis, Treatment, Prognosis
Down Syndrome is a congenital disorder among children commonly born to older mothers. The condition is also known as ‘Up syndrome’ because of the cheerful persona of the Down children.

Pre-natal diagnosis mainly entails sampling fluid, drawn by a needle, from the amniotic sac enveloping the foetus. Another technique is called chorionic villus sampling, and entails taking a sample of placenta.

Both techniques, though, carry a roughly one-percent risk of miscarriage, which is why they are reserved for older mothers-to-be and other women deemed at risk.

Researchers led by Dennis Lo, a professor at the Chinese University of Hong Kong, carried out the first large-scale investigation into new DNA technology which sequences telltale foetal molecules in maternal blood.

A Special Day With Down Syndrome
Time spent at the day care centre of the Down’s Syndrome Association of India can be a lesson in humility and gratitude.

The test was carried out among 753 women who were all in the high-risk category.

Eighty-six of them were found to be carrying a foetus with Down's. The test detected this with 96.6 percent accuracy and did not deliver any "false negatives," meaning that it wrongly said a woman did not have a Down's foetus.

Caring for Children With Down Syndrome - Myths Debunked
Interview with Dr. Rekha Ramachandran a pioneer on Down Syndrome who runs a support group for and raises public awareness on this condition.

"The sequencing test could be used to rule out trisomy 21 among high-risk pregnancies before proceeding to invasive diagnostic testing," says the study, published online by the British Medical Journal (BMJ).

Source-AFP

Amniocentesis
Amniocentesis is a procedure done after 15th week of pregnancy to obtain samples of the amniotic fluid to test for genetic disorders. A simple animation depicting the procedure.